Free Trial

SANUWAVE Health (NASDAQ:SNWV) Releases Quarterly Earnings Results

SANUWAVE Health (NASDAQ:SNWV) Releases Quarterly  Earnings Results

SANUWAVE Health (NASDAQ:SNWV - Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.66) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $9.34 million for the quarter.

SANUWAVE Health Stock Performance

Shares of NASDAQ:SNWV traded down $1.45 during midday trading on Friday, reaching $30.10. The company had a trading volume of 48,639 shares, compared to its average volume of 30,063. The company has a market cap of $257.32 million, a P/E ratio of -6.60 and a beta of 1.25. SANUWAVE Health has a 1-year low of $5.17 and a 1-year high of $39.50.

SANUWAVE Health Company Profile

(Get Free Report)

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.

Further Reading

Should You Invest $1,000 in SANUWAVE Health Right Now?

Before you consider SANUWAVE Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SANUWAVE Health wasn't on the list.

While SANUWAVE Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines